Une coalition d’organisations dirigée par INPUD appelle les pouvoirs publics à reconsidérer l’exclusion de la naloxone comme élément des services de réduction des risques lors de la Conférence internationale sur le VIH/SIDA de 2018. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.
To: Mr. Jan Woldman, Public Health Service of Amsterdam, (GGD, Amsterdam) Ms. Jose Manshande, Public Health Service of Amsterdam (GGD, Amsterdam)
We, as drug user networks and harm reduction organisations, are deeply concerned by the decision of International AIDS Society (IAS) and the Public Health Service of Amsterdam (GGD, Amsterdam) to exclude naloxone as a component of harm reduction services at AIDS 2018. Being the world’s premier gathering on HIV as a global health issue, it is imperative that critical, life-saving medications be made available. Due to this year’s focus on harm reduction and people who use drugs, we expect nothing short of appropriate and comprehensive services, that meet the needs and requirements of conference delegates, be provided by conference organisers.
Naloxone is the antidote to opioid overdose. Ensuring its widespread availability is essential, particularly in a period of an opioid overdose epidemic. Overdose is the principal cause of death of North Americans younger than fifty years old. Similarly, the numbers of drug overdose deaths are rising alarmingly in Europe. The European Monitoring Centre for Drugs and Drug Addiction reported 235 overdose deaths in the Netherlands in 2016. IAS conference delegates unfamiliar with the drugs available in the Netherlands (their potency, purity, quality and/or effects) have considerably increased vulnerability to overdose. We must be blunt: a failure to provide naloxone could well be a failure to save the lives of conference delegates.
The Netherlands has long been recognised for its pragmatic approach to drug use. The selection of Amsterdam, the Netherlands, as the AIDS 2018 host city therefore underscores the failure of IAC and GGD to provide comprehensive harm reduction services for people who use drugs. As a strong and early proponent of harm reduction, The Netherlands has sustained low HIV rates among people who inject drugs. Today, overdose is the highest mortality risk for people who use drugs. Despite legal restrictions around the supply of naloxone, it is incumbent on the IAS and GGD to ensure the safety of all conference delegates. This includes navigating legal restrictions to ensure naloxone is readily available and accessible at AIDS 2018. Without naloxone, delegates who use drugs are considerably more likely to die.
We call for the IAC and GGD to ensure the adequate distribution of naloxone in formats that can be administered safely, easily and effectively. Failing to do so puts people’s lives at risk. AIDS 2018, with its theme of “Breaking Barriers, Building Bridges”, draws attention to rightsbased approaches to more effectively reach key populations. We urge you, as stewards of AIDS 2018, to commit to putting people’s lives first and foremost, and ensure the safety and wellbeing of all conference delegates.
Judy Chang, International Network of People who use Drugs (Global)
Dr. Rick Lines, Harm Reduction International (Global)
Jamie Bridge, International Drug Policy Consortium (Global)
Machteld Busz, Mainline (Global)
Mat Southwell, European Network of People who use Drugs (Europe)
Katrin Schiffer, Correlation Network (Europe)
Eurasian Network of People who use Drugs (Eastern Europe and Central Asia)
Ganna Dovbakh, Eurasian Harm Reduction Association (Eastern Europe and Central Asia)
AFEW International (Eastern Europe and Central Asia)
Hassan Turaif, Middle East and North African Network of People who use Drugs (Middle East and North Africa)
Bikas Gurung, Asian Network of People who use Drugs (Asia-Pacific)
Robert Suarez, North American Network of People who use Drugs (North America)
African Network of People who use Drugs (Africa)
ARASA AIDS & Rights Alliance for Southern Africa (Southern Africa)
Medecins Du Monde (Global)
South African Network of People who use Drugs (South Africa)
Shaun Shelly, TB/HIV Care Association (South Africa)
John Kimani, Kenyan Network of People who use Drugs (Kenya)
Happy Assan, Tanzanian Network of People who use Drugs (Tanzania)
Louise Beale-Vincent, Urban Survivors Union (United States)
Harm Reduction Coalition (United States)
Zimbabwe Civil Liberties and Drugs Network (Zimbabwe)
Intercambios, Puerto Rico (Puerto Rico)
Scottish Drug Users Forum (Scotland)